Treating iron deficiency in patients with heart failure: what, why, when, how, where and who
Open Access
Abstract
For patients with heart failure and reduced or mildly reduced left ventricular ejection fraction, iron deficiency is common and associated with more severe symptoms, worse quality of life and an increased risk of hospitalisations and death. Iron deficiency can be swiftly, effectively and safely treated by administering intravenous iron, either as ferric carboxymaltose or ferric derisomaltose, which improves patient well-being and reduces the risk of hospitalisations including those for heart failure. However, the current definition of iron deficiency in heart failure has serious flaws. A serum ferritin <100 µg/L does not identify patients more likely to respond to intravenous iron. In contrast, patients with transferrin saturations <20%, most of whom are also anaemic, are more likely to have a beneficial response to intravenous iron. In this review, we summarise the available evidence for use of intravenous iron in heart failure and provide recommendations for targeted future research and practical considerations for the general cardiologist.Keywords
Funding Information
- British Heart Foundation (RE/18/6134217)
This publication has 35 references indexed in Scilit:
- Critical Re-Evaluation of the Identification of Iron Deficiency States and Effective Iron Repletion Strategies in Patients with Chronic Heart FailureEuropean Journal of Heart Failure, 2024
- Intravenous Iron and SGLT2 Inhibitors in Iron-Deficient Patients with Heart Failure and Reduced Ejection FractionESC Heart Failure, 2024
- Influence of Serum Transferrin Concentration on Diagnostic Criteria for Iron Deficiency in Chronic Heart FailureESC Heart Failure, 2023
- Intravenous Iron in Patients with Heart Failure and Iron Deficiency: An Updated Meta-AnalysisEuropean Journal of Heart Failure, 2023
- Analysis of Adverse Events and Intravenous Iron Infusion Formulations in Adults With and Without Prior Infusion ReactionsJAMA Network Open, 2022
- Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failureEuropean Journal of Heart Failure, 2021
- High soluble transferrin receptor in patients with heart failure: a measure of iron deficiency and a strong predictor of mortalityEuropean Journal of Heart Failure, 2020
- Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron DeficiencyJAMA, 2017
- Iron Deficiency and Risk of Early Readmission Following a Hospitalization for Acute Heart FailureEuropean Journal of Heart Failure, 2016
- Iron deficiency in chronic heart failure: An international pooled analysisAmerican Heart Journal, 2013